These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 31208361

  • 1. Molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinomas patient with a novel PHF20-NTRK1 fusion: a case report.
    Ge J, Yao B, Huang J, Wu X, Bao H, Ou Q, Shao YW, Chen J.
    BMC Cancer; 2019 Jun 17; 19(1):592. PubMed ID: 31208361
    [Abstract] [Full Text] [Related]

  • 2. Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.
    Xia H, Xue X, Ding H, Ou Q, Wu X, Nagasaka M, Shao YW, Hu X, Ou SI.
    Clin Lung Cancer; 2020 May 17; 21(3):247-254. PubMed ID: 31761448
    [Abstract] [Full Text] [Related]

  • 3. A novel NCOR2-NTRK1 fusion detected in a patient of lung adenocarcinoma and response to larotrectinib: a case report.
    Zhang L, Liu H, Tian Y, Wang H, Yang X.
    BMC Pulm Med; 2021 Apr 17; 21(1):125. PubMed ID: 33865348
    [Abstract] [Full Text] [Related]

  • 4. A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report.
    Zhou N, Schäfer R, Li T, Fang M, Liu L.
    BMC Cancer; 2018 Aug 22; 18(1):842. PubMed ID: 30134855
    [Abstract] [Full Text] [Related]

  • 5. NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.
    Park DY, Choi C, Shin E, Lee JH, Kwon CH, Jo HJ, Kim HR, Kim HS, Oh N, Lee JS, Park OK, Park E, Park J, Shin JY, Kim JI, Seo JS, Park HD, Park J.
    Oncotarget; 2016 Feb 16; 7(7):8399-412. PubMed ID: 26716414
    [Abstract] [Full Text] [Related]

  • 6. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS, Kenudson M, Zheng Z, Liebers M, Cha YJ, Hoang Ho Q, Onozato M, Phi Le L, Heist RS, Iafrate AJ.
    J Thorac Oncol; 2015 Aug 16; 10(8):1156-62. PubMed ID: 26200269
    [Abstract] [Full Text] [Related]

  • 7. The value of biomarkers in patients with sarcomatoid carcinoma of the lung: molecular analysis of 33 cases.
    Jiang X, Liu Y, Chen C, Zhan Z, Yan Q, Guo Y, Wang Q, Li K.
    Clin Lung Cancer; 2012 Jul 16; 13(4):288-96. PubMed ID: 22169481
    [Abstract] [Full Text] [Related]

  • 8. Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies KRAS mutation as a biomarker of poor prognosis.
    Ding Y, Shao Y, Na C, Yin JC, Hua H, Tao R, Jiang Y, Hu R, He X, Miao C, Zhu D, Zhang Z.
    J Med Genet; 2022 Jan 16; 59(1):10-17. PubMed ID: 33115932
    [Abstract] [Full Text] [Related]

  • 9. Stepwise addition of genetic changes correlated with histological change from "well-differentiated" to "sarcomatoid" phenotypes: a case report.
    Goto T, Hirotsu Y, Mochizuki H, Nakagomi T, Oyama T, Amemiya K, Omata M.
    BMC Cancer; 2017 Jan 19; 17(1):65. PubMed ID: 28103823
    [Abstract] [Full Text] [Related]

  • 10. Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
    Schrock AB, Li SD, Frampton GM, Suh J, Braun E, Mehra R, Buck SC, Bufill JA, Peled N, Karim NA, Hsieh KC, Doria M, Knost J, Chen R, Ou SI, Ross JS, Stephens PJ, Fishkin P, Miller VA, Ali SM, Halmos B, Liu JJ.
    J Thorac Oncol; 2017 Jun 19; 12(6):932-942. PubMed ID: 28315738
    [Abstract] [Full Text] [Related]

  • 11. Molecular classification of pulmonary sarcomatoid carcinomas suggests new therapeutic opportunities.
    Pécuchet N, Vieira T, Rabbe N, Antoine M, Blons H, Cadranel J, Laurent-Puig P, Wislez M.
    Ann Oncol; 2017 Jul 01; 28(7):1597-1604. PubMed ID: 28419182
    [Abstract] [Full Text] [Related]

  • 12. High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.
    Fallet V, Saffroy R, Girard N, Mazieres J, Lantuejoul S, Vieira T, Rouquette I, Thivolet-Bejui F, Ung M, Poulot V, Schlick L, Moro-Sibilot D, Antoine M, Cadranel J, Lemoine A, Wislez M.
    Ann Oncol; 2015 Aug 01; 26(8):1748-53. PubMed ID: 25969368
    [Abstract] [Full Text] [Related]

  • 13. A Case of Inv(1)(q23q31) TPR-NTRK1 Fusion-Positive Spindle Cell Neoplasm in an Infant-Uncovered by Next-Generation Sequencing: Diagnostic Challenge, Review, and Therapeutic Implications.
    Rekhi B, Shetty O, Bapat P, Gurav M, Qureshi S.
    Int J Surg Pathol; 2021 Feb 01; 29(1):102-108. PubMed ID: 32489127
    [Abstract] [Full Text] [Related]

  • 14. Basal cell carcinosarcoma with PTCH1 mutations in both epithelial and sarcomatoid primary tumor components and in the sarcomatoid metastasis.
    Kiuru M, McDermott G, Coit DC, Berger MF, Busam KJ.
    Am J Surg Pathol; 2014 Jan 01; 38(1):138-42. PubMed ID: 24335643
    [Abstract] [Full Text] [Related]

  • 15. Genetic heterogeneity and predictive biomarker for pulmonary sarcomatoid carcinomas.
    Qin J, Chen B, Li C, Yan J, Lu H.
    Cancer Genet; 2021 Jan 01; 250-251():12-19. PubMed ID: 33217678
    [Abstract] [Full Text] [Related]

  • 16. EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy.
    Italiano A, Cortot AB, Ilie M, Martel-Planche G, Fabas T, Pop D, Mouroux J, Hofman V, Hofman P, Pedeutour F.
    Int J Cancer; 2009 Nov 15; 125(10):2479-82. PubMed ID: 19681124
    [Abstract] [Full Text] [Related]

  • 17. Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors.
    Agaram NP, Zhang L, Sung YS, Chen CL, Chung CT, Antonescu CR, Fletcher CD.
    Am J Surg Pathol; 2016 Oct 15; 40(10):1407-16. PubMed ID: 27259011
    [Abstract] [Full Text] [Related]

  • 18. Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment.
    Chen W, Wang H, Jiang D, Luan L, Zhou Y, Hou Y.
    World J Surg Oncol; 2021 Apr 30; 19(1):136. PubMed ID: 33941195
    [Abstract] [Full Text] [Related]

  • 19. Next-generation sequencing analysis identifies genomic alterations in pathological morphologies: A case of pulmonary carcinosarcoma harboring EGFR mutations.
    Koba H, Kimura H, Nishikawa S, Sone T, Abo M, Hara J, Hosomichi K, Tajima A, Kasahara K.
    Lung Cancer; 2018 Aug 30; 122():146-150. PubMed ID: 30032823
    [Abstract] [Full Text] [Related]

  • 20. Maxillary carcinosarcoma: Identification of a novel MET mutation in both carcinomatous and sarcomatous components through next generation sequencing.
    Ando M, Saito Y, Morikawa T, Omura G, Kobayashi K, Akashi K, Yoshida M, Ebihara Y, Fujimoto C, Fukayama M, Yamasoba T, Asakage T.
    Head Neck; 2015 Dec 30; 37(12):E179-85. PubMed ID: 25782598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.